Mimedx (MDXG) Goodwill & Intangibles (2010 - 2026)
Mimedx recorded quarterly Goodwill & Intangibles of $32.6 million in Q1 2026, down 3.03% quarter-over-quarter from $33.6 million in Q4 2025, and up 6.81% year-over-year from $30.5 million in Q1 2025.
Mimedx's Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $32.6 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 6.81% year-over-year to $32.6 million; the TTM figure through Mar 2026 stood at $32.6 million (up 6.81% YoY), while the FY2025 annual figure was $33.6 million, up 8.15% from the prior year.
- Goodwill & Intangibles came in at $32.6 million for Q1 2026 at Mimedx, down from $33.6 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $33.6 million in Q4 2025 to a low of $24.7 million in Q4 2023.
- A 5-year average of $28.5 million and a median of $30.5 million in 2025 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles climbed 25.92% in 2024 and slipped 4.65% in 2025, its largest moves.
- Mimedx's Goodwill & Intangibles stood at $25.3 million in 2022, then dropped by 2.35% to $24.7 million in 2023, then climbed by 25.79% to $31.1 million in 2024, then gained by 8.15% to $33.6 million in 2025, then fell by 3.03% to $32.6 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $32.6 million, $33.6 million, and $30.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.58 Mn |
| Dec 31, 2025 | 33.60 Mn |
| Sep 30, 2025 | 30.59 Mn |
| Jun 30, 2025 | 31.47 Mn |
| Mar 31, 2025 | 30.50 Mn |
| Dec 31, 2024 | 31.07 Mn |
| Sep 30, 2024 | 30.64 Mn |
| Jun 30, 2024 | 31.49 Mn |
| Mar 31, 2024 | 31.99 Mn |
| Dec 31, 2023 | 24.70 Mn |
| Sep 30, 2023 | 24.84 Mn |
| Jun 30, 2023 | 25.01 Mn |
| Mar 31, 2023 | 25.68 Mn |
| Dec 31, 2022 | 25.29 Mn |
| Sep 30, 2022 | 24.97 Mn |
| Jun 30, 2022 | 25.12 Mn |
| Mar 31, 2022 | 25.24 Mn |
| Dec 31, 2021 | 24.82 Mn |
| Sep 30, 2021 | 25.60 Mn |
| Jun 30, 2021 | 25.73 Mn |
| Mar 31, 2021 | 25.89 Mn |
| Dec 31, 2020 | 25.98 Mn |
| Sep 30, 2020 | 27.14 Mn |
| Jun 30, 2020 | 27.36 Mn |
| Mar 31, 2020 | 27.56 Mn |
| Dec 31, 2019 | 27.75 Mn |
| Sep 30, 2019 | 27.93 Mn |
| Jun 30, 2019 | 28.08 Mn |
| Mar 31, 2019 | 28.27 Mn |
| Dec 31, 2018 | 29.58 Mn |
| Dec 31, 2017 | 30.01 Mn |
| Sep 30, 2017 | 30.58 Mn |
| Jun 30, 2017 | 42.49 Mn |
| Mar 31, 2017 | 42.99 Mn |
| Dec 31, 2016 | 43.46 Mn |
| Sep 30, 2016 | 54.20 Mn |
| Jun 30, 2016 | 54.64 Mn |
| Mar 31, 2016 | 60.40 Mn |
| Dec 31, 2015 | 14.80 Mn |
| Sep 30, 2015 | 14.78 Mn |
| Jun 30, 2015 | 14.82 Mn |
| Mar 31, 2015 | 14.85 Mn |
| Dec 31, 2014 | 14.89 Mn |
| Sep 30, 2014 | 15.00 Mn |
| Jun 30, 2014 | 15.04 Mn |
| Mar 31, 2014 | 15.16 Mn |
| Dec 31, 2013 | 15.22 Mn |
| Sep 30, 2013 | 15.69 Mn |
| Jun 30, 2013 | 15.76 Mn |
| Mar 31, 2013 | 19.77 Mn |
| Dec 31, 2012 | 15.95 Mn |
| Sep 30, 2012 | 21.57 Mn |
| Jun 30, 2012 | 18.46 Mn |
| Mar 31, 2012 | 18.80 Mn |
| Dec 31, 2011 | 21.57 Mn |
| Sep 30, 2011 | 19.46 Mn |
| Jun 30, 2011 | 19.80 Mn |
| Dec 31, 2010 | 4.79 Mn |